Cardinal Health (CAH) 81.79 $CAH
Cardinal Health Set to Possibly Pullback After Yesterday's Rally of 2.51%
Comtex SmarTrend(R) - Wed Jul 06, 1:25PM CDT
Cardinal Health (NYSE:CAH) traded in a range yesterday that spanned from a low of $77.77 to a high of $80.19. Yesterday, the shares gained 2.5%, which took the trading range above the 3-day high of $78.69 on volume of 1.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
CAH: 81.79 (+0.73)
Watch for Cardinal Health to Potentially Pullback After Gaining 2.51% Yesterday
Comtex SmarTrend(R) - Wed Jul 06, 1:24PM CDT
Cardinal Health (NYSE:CAH) traded in a range yesterday that spanned from a low of $77.77 to a high of $80.19. Yesterday, the shares gained 2.5%, which took the trading range above the 3-day high of $78.69 on volume of 1.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
CAH: 81.79 (+0.73)
Akers Biosciences Chlamydia Rapid Test Results Positive
Zacks Equity Research - Zacks Investment Research - Fri Jul 01, 8:33AM CDT
Shares of Akers Biosciences Inc. (AKER) surged 15.8% to close at $3.22 following the completion of a clinical trial on the company's Chlamydia rapid test.
BSX: 23.75 (-0.02), ICUI: 114.77 (-0.97), CAH: 81.79 (+0.73), AKER: 2.76 (-0.04)
Cardinal Health Appoints Pamela O. Kimmet Chief Human Resources Officer
PR Newswire - Thu Jun 30, 3:15PM CDT
Cardinal Health, a global healthcare services and products company, today announced the appointment of Pamela O. Kimmet as Chief Human Resources Officer, effective today. Pam joins the company from Coca-Cola Enterprises, where she was senior vice president, Human Resources. She will report to George S. Barrett, chairman and CEO of Cardinal Health.
CAH: 81.79 (+0.73)
Look for Shares of Cardinal Health to Potentially Pullback after Yesterday's 2.36% Rise
Comtex SmarTrend(R) - Wed Jun 29, 4:11PM CDT
Cardinal Health (NYSE:CAH) traded in a range yesterday that spanned from a low of $75.69 to a high of $77.21. Yesterday, the shares gained 2.4%, which took the trading range above the 3-day high of $76.25 on volume of 1.0 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
CAH: 81.79 (+0.73)
Akers Biosciences Signs Distribution Agreement, Shares Rally
Zacks Equity Research - Zacks Investment Research - Tue Jun 28, 6:49AM CDT
Akers Biosciences Inc. (AKER) recently signed an agreement with Aero-Med, a division of Cardinal Health (CAH), to distribute its disposable breathalyzer.
BSX: 23.75 (-0.02), ICUI: 114.77 (-0.97), CAH: 81.79 (+0.73), AKER: 2.76 (-0.04)
SmarTrend Watching for Potential Rebound in Shares of Cardinal Health After 1.37% Loss
Comtex SmarTrend(R) - Wed Jun 15, 11:58AM CDT
Cardinal Health (NYSE:CAH) traded in a range yesterday that spanned from a low of $76.67 to a high of $78.08. Yesterday, the shares fell 1.4%, which took the trading range below the 3-day low of $77.57 on volume of 1.5 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
CAH: 81.79 (+0.73)
Cardinal Health to Prepare NETSPOT(TM) Doses for Advanced Accelerator Applications
GlobeNewswire - Thu Jun 09, 6:51AM CDT
Advanced Accelerator Applications S.A. (NASDAQ:AAAP) ("AAA" or "the Company"
, an international specialist in Molecular Nuclear Medicine (MNM), today announced that it has selected Cardinal Health, Inc. (NYSE:CAH), a healthcare services company operating the largest radiopharmaceutical network in the United States, to supply gallium 68 (Ga 68) dotatate doses prepared with a novel kit to U.S. hospitals and imaging centers.
CAH: 81.79 (+0.73), AAAP: 30.88 (-0.10)
Sterigenics International Names Michael B. Petras, Jr. as Chief Executive Officer
PR Newswire - Wed Jun 01, 12:00PM CDT
Sterigenics International LLC ("Sterigenics" or "the Company", the leading global provider of contract sterilization, gamma technologies and medical isotopes, and a portfolio company of Warburg Pincus and GTCR, today announced that Michael B. Petras, Jr. has been appointed Chief Executive Officer ("CEO", effective June 20, 2016. Mr. Petras succeeds Michael Mulhern, who has been appointed to serve as Executive Chairman of the Sterigenics Board of Directors.
CAH: 81.79 (+0.73)
SmarTrend Watching for Potential Pullback in Shares of Cardinal Health After 1.26% Gain
Comtex SmarTrend(R) - Fri May 27, 12:33PM CDT
Cardinal Health (NYSE:CAH) traded in a range yesterday that spanned from a low of $77.45 to a high of $78.36. Yesterday, the shares gained 1.3%, which took the trading range above the 3-day high of $77.99 on volume of 668,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
CAH: 81.79 (+0.73)
Cardinal Health Set to Possibly Pullback After Yesterday's Rally of 1.26%
Comtex SmarTrend(R) - Fri May 27, 12:31PM CDT
Cardinal Health (NYSE:CAH) traded in a range yesterday that spanned from a low of $77.45 to a high of $78.36. Yesterday, the shares gained 1.3%, which took the trading range above the 3-day high of $77.99 on volume of 668,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
CAH: 81.79 (+0.73)
Fort McMurray Fire Victims to Receive Aid from Cardinal Health
CNW Group - Tue May 17, 8:00AM CDT
Company donates more than $85,000 in cash and health care products
CAH: 81.79 (+0.73)
Cordis Announces Return to the Drug-Eluting Stent Market
PR Newswire - Thu May 12, 8:00AM CDT
Cardinal Health today announced that it has entered into a distribution agreement with Biosensors that enables Cordis, Cardinal Health's interventional vascular business, to sell Biosensors' coronary stent portfolio. Cordis will sell Biosensors' coronary stents in select countries in Europe, the Middle East, Africa, Australia and New Zealand. This marks Cordis' return to the drug-eluting stent (DES) market and the beginning of a long-term partnership between Cardinal Health and Biosensors to further leverage their respective distribution capabilities in select regions.
CAH: 81.79 (+0.73)
Moving Average Crossover Alert: Cardinal Health (CAH)
Zacks Equity Research - Zacks Investment Research - Mon May 09, 9:12AM CDT
Cardinal Health, Inc. (CAH) could be a stock to avoid from a technical perspective, as the firm is seeing unfavorable trends on the moving average crossover front
CAH: 81.79 (+0.73)
/C O R R E C T I O N -- Cardinal Health/
PR Newswire - Wed May 04, 4:40PM CDT
In the news release, Cardinal Health Board of Directors Approves Quarterly Dividend, Authorizes Share Repurchase Program, issued 04-May-2016 by Cardinal Health over PR Newswire, we are advised by the company that the first paragraph, second sentence, should read, "The quarterly dividend is payable on July 15, 2016, to shareholders of record at the close of business on July 1, 2016." rather than, "The quarterly dividend is payable on July 15, 2016, to shareholders of record at the close of business on July 1, 2015." as originally issued inadvertently. The complete, corrected release follows:
CAH: 81.79 (+0.73)
Cardinal Health Board of Directors Approves Quarterly Dividend, Authorizes Share Repurchase Program
PR Newswire - Wed May 04, 3:08PM CDT
Cardinal Health today announced that its board of directors approved a 16 percent increase in the company's quarterly dividend to $0.4489 per share, or $1.80 per share on an annualized basis. The quarterly dividend is payable on July 15, 2016, to shareholders of record at the close of business on July 1, 2015.
CAH: 81.79 (+0.73)
Watch for Cardinal Health to Potentially Rebound After Falling 6.94% Yesterday
Comtex SmarTrend(R) - Thu Apr 28, 12:14PM CDT
Cardinal Health (NYSE:CAH) traded in a range yesterday that spanned from a low of $79.36 to a high of $83.91. Yesterday, the shares fell 6.9%, which took the trading range below the 3-day low of $85.72 on volume of 3.3 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
CAH: 81.79 (+0.73)
Cardinal Health (CAH) Tops Q3 Earnings, FY16 View Revised
Zacks Equity Research - Zacks Investment Research - Thu Apr 28, 8:23AM CDT
Cardinal Health (CAH) reported third-quarter fiscal 2016 adjusted earnings of $1.43 per share, which beat the Zacks Consensus Estimate by a dime.
ALGN: 84.37 (+1.00), CAH: 81.79 (+0.73), CVS: 96.06 (-0.78), HSIC: 181.77 (-0.01)
Cardinal Health Set to Possibly Pullback After Yesterday's Rally of 2.51%
Comtex SmarTrend(R) - Wed Jul 06, 1:25PM CDT
Cardinal Health (NYSE:CAH) traded in a range yesterday that spanned from a low of $77.77 to a high of $80.19. Yesterday, the shares gained 2.5%, which took the trading range above the 3-day high of $78.69 on volume of 1.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
CAH: 81.79 (+0.73)
Watch for Cardinal Health to Potentially Pullback After Gaining 2.51% Yesterday
Comtex SmarTrend(R) - Wed Jul 06, 1:24PM CDT
Cardinal Health (NYSE:CAH) traded in a range yesterday that spanned from a low of $77.77 to a high of $80.19. Yesterday, the shares gained 2.5%, which took the trading range above the 3-day high of $78.69 on volume of 1.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
CAH: 81.79 (+0.73)
Akers Biosciences Chlamydia Rapid Test Results Positive
Zacks Equity Research - Zacks Investment Research - Fri Jul 01, 8:33AM CDT
Shares of Akers Biosciences Inc. (AKER) surged 15.8% to close at $3.22 following the completion of a clinical trial on the company's Chlamydia rapid test.
BSX: 23.75 (-0.02), ICUI: 114.77 (-0.97), CAH: 81.79 (+0.73), AKER: 2.76 (-0.04)
Cardinal Health Appoints Pamela O. Kimmet Chief Human Resources Officer
PR Newswire - Thu Jun 30, 3:15PM CDT
Cardinal Health, a global healthcare services and products company, today announced the appointment of Pamela O. Kimmet as Chief Human Resources Officer, effective today. Pam joins the company from Coca-Cola Enterprises, where she was senior vice president, Human Resources. She will report to George S. Barrett, chairman and CEO of Cardinal Health.
CAH: 81.79 (+0.73)
Look for Shares of Cardinal Health to Potentially Pullback after Yesterday's 2.36% Rise
Comtex SmarTrend(R) - Wed Jun 29, 4:11PM CDT
Cardinal Health (NYSE:CAH) traded in a range yesterday that spanned from a low of $75.69 to a high of $77.21. Yesterday, the shares gained 2.4%, which took the trading range above the 3-day high of $76.25 on volume of 1.0 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
CAH: 81.79 (+0.73)
Akers Biosciences Signs Distribution Agreement, Shares Rally
Zacks Equity Research - Zacks Investment Research - Tue Jun 28, 6:49AM CDT
Akers Biosciences Inc. (AKER) recently signed an agreement with Aero-Med, a division of Cardinal Health (CAH), to distribute its disposable breathalyzer.
BSX: 23.75 (-0.02), ICUI: 114.77 (-0.97), CAH: 81.79 (+0.73), AKER: 2.76 (-0.04)
SmarTrend Watching for Potential Rebound in Shares of Cardinal Health After 1.37% Loss
Comtex SmarTrend(R) - Wed Jun 15, 11:58AM CDT
Cardinal Health (NYSE:CAH) traded in a range yesterday that spanned from a low of $76.67 to a high of $78.08. Yesterday, the shares fell 1.4%, which took the trading range below the 3-day low of $77.57 on volume of 1.5 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
CAH: 81.79 (+0.73)
Cardinal Health to Prepare NETSPOT(TM) Doses for Advanced Accelerator Applications
GlobeNewswire - Thu Jun 09, 6:51AM CDT
Advanced Accelerator Applications S.A. (NASDAQ:AAAP) ("AAA" or "the Company"
, an international specialist in Molecular Nuclear Medicine (MNM), today announced that it has selected Cardinal Health, Inc. (NYSE:CAH), a healthcare services company operating the largest radiopharmaceutical network in the United States, to supply gallium 68 (Ga 68) dotatate doses prepared with a novel kit to U.S. hospitals and imaging centers. CAH: 81.79 (+0.73), AAAP: 30.88 (-0.10)
Sterigenics International Names Michael B. Petras, Jr. as Chief Executive Officer
PR Newswire - Wed Jun 01, 12:00PM CDT
Sterigenics International LLC ("Sterigenics" or "the Company"
, the leading global provider of contract sterilization, gamma technologies and medical isotopes, and a portfolio company of Warburg Pincus and GTCR, today announced that Michael B. Petras, Jr. has been appointed Chief Executive Officer ("CEO", effective June 20, 2016. Mr. Petras succeeds Michael Mulhern, who has been appointed to serve as Executive Chairman of the Sterigenics Board of Directors. CAH: 81.79 (+0.73)
SmarTrend Watching for Potential Pullback in Shares of Cardinal Health After 1.26% Gain
Comtex SmarTrend(R) - Fri May 27, 12:33PM CDT
Cardinal Health (NYSE:CAH) traded in a range yesterday that spanned from a low of $77.45 to a high of $78.36. Yesterday, the shares gained 1.3%, which took the trading range above the 3-day high of $77.99 on volume of 668,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
CAH: 81.79 (+0.73)
Cardinal Health Set to Possibly Pullback After Yesterday's Rally of 1.26%
Comtex SmarTrend(R) - Fri May 27, 12:31PM CDT
Cardinal Health (NYSE:CAH) traded in a range yesterday that spanned from a low of $77.45 to a high of $78.36. Yesterday, the shares gained 1.3%, which took the trading range above the 3-day high of $77.99 on volume of 668,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
CAH: 81.79 (+0.73)
Fort McMurray Fire Victims to Receive Aid from Cardinal Health
CNW Group - Tue May 17, 8:00AM CDT
Company donates more than $85,000 in cash and health care products
CAH: 81.79 (+0.73)
Cordis Announces Return to the Drug-Eluting Stent Market
PR Newswire - Thu May 12, 8:00AM CDT
Cardinal Health today announced that it has entered into a distribution agreement with Biosensors that enables Cordis, Cardinal Health's interventional vascular business, to sell Biosensors' coronary stent portfolio. Cordis will sell Biosensors' coronary stents in select countries in Europe, the Middle East, Africa, Australia and New Zealand. This marks Cordis' return to the drug-eluting stent (DES) market and the beginning of a long-term partnership between Cardinal Health and Biosensors to further leverage their respective distribution capabilities in select regions.
CAH: 81.79 (+0.73)
Moving Average Crossover Alert: Cardinal Health (CAH)
Zacks Equity Research - Zacks Investment Research - Mon May 09, 9:12AM CDT
Cardinal Health, Inc. (CAH) could be a stock to avoid from a technical perspective, as the firm is seeing unfavorable trends on the moving average crossover front
CAH: 81.79 (+0.73)
/C O R R E C T I O N -- Cardinal Health/
PR Newswire - Wed May 04, 4:40PM CDT
In the news release, Cardinal Health Board of Directors Approves Quarterly Dividend, Authorizes Share Repurchase Program, issued 04-May-2016 by Cardinal Health over PR Newswire, we are advised by the company that the first paragraph, second sentence, should read, "The quarterly dividend is payable on July 15, 2016, to shareholders of record at the close of business on July 1, 2016." rather than, "The quarterly dividend is payable on July 15, 2016, to shareholders of record at the close of business on July 1, 2015." as originally issued inadvertently. The complete, corrected release follows:
CAH: 81.79 (+0.73)
Cardinal Health Board of Directors Approves Quarterly Dividend, Authorizes Share Repurchase Program
PR Newswire - Wed May 04, 3:08PM CDT
Cardinal Health today announced that its board of directors approved a 16 percent increase in the company's quarterly dividend to $0.4489 per share, or $1.80 per share on an annualized basis. The quarterly dividend is payable on July 15, 2016, to shareholders of record at the close of business on July 1, 2015.
CAH: 81.79 (+0.73)
Watch for Cardinal Health to Potentially Rebound After Falling 6.94% Yesterday
Comtex SmarTrend(R) - Thu Apr 28, 12:14PM CDT
Cardinal Health (NYSE:CAH) traded in a range yesterday that spanned from a low of $79.36 to a high of $83.91. Yesterday, the shares fell 6.9%, which took the trading range below the 3-day low of $85.72 on volume of 3.3 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
CAH: 81.79 (+0.73)
Cardinal Health (CAH) Tops Q3 Earnings, FY16 View Revised
Zacks Equity Research - Zacks Investment Research - Thu Apr 28, 8:23AM CDT
Cardinal Health (CAH) reported third-quarter fiscal 2016 adjusted earnings of $1.43 per share, which beat the Zacks Consensus Estimate by a dime.
ALGN: 84.37 (+1.00), CAH: 81.79 (+0.73), CVS: 96.06 (-0.78), HSIC: 181.77 (-0.01)
